Pharma & drug development · Reference
What is pharmacodynamics?
Pharmacodynamics (PD) is the study of what a drug does to the body. It examines how drugs act on receptors and other targets to produce effects, including the concepts of agonists and antagonists and the dose–response relationship.
Drugs, targets and receptors
Pharmacodynamics explains how a drug produces its effect. Most drugs act on specific molecular targets, frequently receptors — proteins that, when engaged, trigger a biological response. A drug that activates a receptor is an agonist; one that blocks it, preventing activation, is an antagonist. This target-based view is the conceptual mirror of pharmacokinetics: where PK asks how much drug reaches the site of action, PD asks what happens when it gets there. Understanding the target is also why drug discovery begins with target identification.
Dose–response, efficacy and potency
A central idea in pharmacodynamics is the dose–response relationship: as the amount of drug at the target increases, the size of the effect typically changes in a characteristic way. Two related concepts help describe this. Efficacy is the maximum effect a drug can produce, while potency refers to the amount of drug needed to produce a given effect. A potent drug achieves an effect at a smaller quantity, but potency and efficacy are independent — a less potent drug can have greater maximum effect. These are educational, concept-level descriptors, not statements about clinical dosing.
Pharmacodynamics in research
Pharmacodynamic characterisation is essential throughout drug development. Preclinical and early clinical studies measure how a candidate engages its target and what effects result, helping to confirm that the intended mechanism operates as expected. Combined with pharmacokinetic data, this PK/PD picture explains how drug exposure over time translates into effect.
Pharmacodynamics also underpins toxicology, because adverse effects often arise from a drug acting on unintended targets or producing excessive effects at its intended one. As a discipline it describes mechanisms of action for research purposes and does not offer guidance for personal use.
Key facts
At a glance
- Definition: What the drug does to the body
- Targets: Often receptors and other proteins
- Agonist: Activates a receptor
- Antagonist: Blocks a receptor
- Dose–response: Effect changes with amount at the target
- Efficacy vs potency: Maximum effect vs amount needed
Common questions
FAQ
What is pharmacodynamics in simple terms?+
Pharmacodynamics is the study of what a drug does to the body — how it acts on targets such as receptors to produce effects. It is the complement to pharmacokinetics and is an educational, mechanistic concept rather than dosing advice.
What is the difference between an agonist and an antagonist?+
An agonist is a drug that activates a receptor to produce a response, while an antagonist binds the receptor and blocks it, preventing activation. Both are core pharmacodynamic concepts describing how drugs act at their targets.
What is the difference between efficacy and potency?+
Efficacy is the maximum effect a drug can produce, whereas potency is the amount of drug needed to produce a given effect. They are independent: a drug can be potent but have low maximum efficacy, or vice versa.
The step most authors miss
Doing CRediT right? Don’t stop at the statement.
A CRediT statement credits you inside one paper. The recognition CRediT was built for happens when those roles are tied to you, persistently. Sign in with your ORCID — free — and claim your CRediT contributions on casrai.org, the home of the standard. They become a verified, portable part of your identity, not a line that disappears into one PDF.
Free: claim your contributions, then export a journal-ready CRediT statement, schema.org structured data, JATS XML, CSV or BibTeX — and preview your public profile. A membership publishes that profile publicly and verifies the journals you serve.
